WEBULL
News
SPHDF
21.15
NaN%
--
Weekly Report: what happened at SPHDF last week (0223-0227)?
Weekly Report · 2d ago
Weekly Report: what happened at SPHDF last week (0216-0220)?
Weekly Report · 02/23 10:17
Weekly Report: what happened at SPHDF last week (0209-0213)?
Weekly Report · 02/16 10:17
Weekly Report: what happened at SPHDF last week (0202-0206)?
Weekly Report · 02/09 10:18
Weekly Report: what happened at SPHDF last week (0126-0130)?
Weekly Report · 02/02 10:18
Weekly Report: what happened at SPHDF last week (0119-0123)?
Weekly Report · 01/26 10:18
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Santhera Pharmaceuticals Holding (OtherSPHDF), Nuvalent (NUVL) and Hims & Hers Health (HIMS)
TipRanks · 01/20 11:31
Weekly Report: what happened at SPHDF last week (0112-0116)?
Weekly Report · 01/19 10:24
Swissmedic Approves Santhera's AGAMREE For Duchenne Muscular Dystrophy
NASDAQ · 01/15 06:39
Weekly Report: what happened at SPHDF last week (0105-0109)?
Weekly Report · 01/12 10:23
Weekly Report: what happened at SPHDF last week (1229-0102)?
Weekly Report · 01/05 10:17
Weekly Report: what happened at SPHDF last week (1222-1226)?
Weekly Report · 12/29/2025 10:17
Weekly Report: what happened at SPHDF last week (1215-1219)?
Weekly Report · 12/22/2025 10:16
Weekly Report: what happened at SPHDF last week (1208-1212)?
Weekly Report · 12/15/2025 10:23
Weekly Report: what happened at SPHDF last week (1201-1205)?
Weekly Report · 12/08/2025 10:22
Weekly Report: what happened at SPHDF last week (1124-1128)?
Weekly Report · 12/01/2025 10:18
Weekly Report: what happened at SPHDF last week (1117-1121)?
Weekly Report · 11/24/2025 10:22
Weekly Report: what happened at SPHDF last week (1110-1114)?
Weekly Report · 11/17/2025 10:22
Weekly Report: what happened at SPHDF last week (1103-1107)?
Weekly Report · 11/10/2025 10:20
Analysts Offer Insights on Healthcare Companies: Caribou Biosciences (CRBU), Santhera Pharmaceuticals Holding (OtherSPHDF) and BioCryst (BCRX)
TipRanks · 11/04/2025 14:10
More
Webull provides a variety of real-time SPHDF stock news. You can receive the latest news about Santhera Pharmaceuticals Hldgs through multiple platforms. This information may help you make smarter investment decisions.
About SPHDF
Santhera Pharmaceuticals Holding AG (Santhera) is a Switzerland-based company engaged in the pharmaceutical sector. The Company operates through one business segment, which is the research, development and commercialization of pharmaceutical products for the treatment of neuromuscular and mitochondrial diseases, such as Duchenne muscular dystrophy (DMD) and cystic fibrosis (CF). The Company focuses also on development of gene therapy for the treatment of LAMA2 (Laminin Subunit Alpha 2) deficient congenital muscular dystrophy (CMD). Santhera operates through its wholly owned subsidiaries: Santhera Pharmaceuticals (Schweiz) AG, Liestal, Santhera Pharmaceuticals (USA) Inc, Santhera Pharmaceuticals (Canada) Inc, Santhera Pharmaceutical (Deutschland) GmbH and Oy Santhera Pharmaceuticals (Finland) Ltd.